Robert Bucelli is a Neurology physician affiliated with Valve. OpenAlex indexes 127 publications with 3,806 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4921 Parkview Pl
Div Neurology Neuromuscular, Ste 6c
Saint Louis, MO 631101032
Telephone
314-362-6981Registry record last updated 15 Apr 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sarepta Therapeutics, Inc.Program year20255 payments
- PFIZER INC.Program year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year202412 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
77.3%Gabapentinoids37.5%Pregabalin51%Gabapentin50%Part D≥13 patientsSNRI16.5%Duloxetine Hcl77%Venlafaxine Hcl Er23%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
12.7%Corticosteroid12.7%Prednisone100%Part D≥11 patientsMusculoskeletal
6.2%gamma-Aminobutyric Acid-ergic Agonist6.2%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tofersen treatment leads to sustained stabilization of disease in <scp>SOD1 ALS</scp> in a “real‐world” setting
Annals of Clinical and Translational Neurology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Vinod Thourani, MD
Valve
Vasilis Babaliaros, MD
Valve
Jeffrey Borer, MD
Valve
Lauren Elman, MD
Valve
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”